As such, the depletion of ST6Gal1 led to decreased CD133+/ALDH1+ colon CSCs and an impaired tumor-initiating potential in PDAC MiaPaCa2 cells, as determined by in vivo limiting dilution assays [7,40]. Here, ST6GAL1 is linked to neoplasm.